Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Deep Dive: Breast Cancer – ER+ Metastatic Breast Cancer: Refining Practice and Steering Research 2024

Aired live on 03 Jul 2024


This content is for ESMO members only.



Download slides

CME test

2 ESMO - MORA points


Welcome and introduction
Peter Schmid
How to tackle endocrine resistance? Current concepts and ongoing research
Stephen Johnston
Breakthrough research on the Role of liquid biopsy and molecular analysis
Francois-Clement Bidard
What to do with endocrine refractory patients? Current concepts and ongoing research
Alessandra Gennari
LIVE Discussion and Q&A


This ESMO Deep Dive Breast Cancer Webinar focusd on breakthroughs in personalised, molecularly informed risk prediction, screening and early detection in breast cancer.

This webinar was developed with the aim to provide a second, deeper layer of educational experience in emerging data related to: molecular biology and classification, translational research and biomarkers for precision medicine, and unknowns, hypotheses, and ongoing research in areas of controversy or unmet need for optimal management of patients.

It began with a brief welcome and introduction, then a lecture on how to tackle endocrine resistance, discussing current concepts and ongoing research. This was followed by a talk on breakthrough research on the role of liquid biopsy and molecular analysis, and lastly, by a discussion on the best approach on endocrine refractory patients. The lectures were followed by a live discussion with the speakers’ panel.

This programme was designed to provide an overview of the latest understanding of molecular biology and the impact of targeting different pathways in the management of patients with breast cancers, offer expert opinion exchange, and provide some important considerations in this field.

Learning objectives

  • To acquire a deeper understanding of the clinical course of malignant disease of breast cancer
  • To understand biological hypotheses on classification and risk stratification, ongoing/required research in therapeutics and knowledge of use of omics technologies for biomarker-enabled precision medicine for breast cancer
  • To develop skills and abilities for critical analysis, interpretation of research data and therapeutic strategies
  • To become better equipped for informed, innovative thinking and engagement in ongoing or new research projects

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.